HOME >> BIOLOGY >> NEWS
Acetaminophen may protect against heart damage according to Rutgers research

NEW BRUNSWICK/PISCATAWAY, N.J. New research from Rutgers, The State University of New Jersey, links acetaminophen, the medicine in pain relievers such as Tylenol, to improved heart muscle recovery following ischemic attacks periods of reduced blood flow typical of coronary artery disease.

Laboratory findings reported by Professor Gary F. Merrill, Rutgers' department of cell biology and neuroscience, indicate a significant improvement in acetaminophen-treated hearts compared with non-treated hearts following periods of induced ischemia.

"Our goal over the past few years has been to examine the potential protective effect of acetaminophen on the function of the heart muscle and coronary circulation," said Merrill.

"We now have results from several published studies that suggest acetaminophen exerts an antioxidant effect on heart muscle cells, blocking the damage caused by chemicals known as oxidants." Merrill attributed the rapid post-ischemia recovery of heart muscle function and circulation observed to the antioxidant properties of acetaminophen.

"We are extremely encouraged by these preliminary findings and look forward to future investigations to confirm them in humans," said Merrill. "In the interim, we do not recommend that acetaminophen users deviate from recommended dosages," he added.

Ischemic heart disease is a widely recognized precursor to heart attack. Episodes of ischemia, which are generally accompanied by the painful condition called angina pectoris, are the result of reduced blood flow through the coronary arteries that supply vital oxygen to the heart muscle. As coronary arteries become progressively narrowed due to fatty deposits on the inside of their walls, their ability to sustain adequate blood flow diminishes.

According to the American Heart Association, heart disease is the country's number one killer of both men and women. In 1999 alone, it claimed nearly 700,000 lives.


'"/>

Contact: Joseph Blumberg
blumberg@ur.rutgers.edu
732-932-7084 x652
Rutgers, the State University of New Jersey
15-Jul-2002


Page: 1 2

Related biology news :

1. Intake Of Acetaminophen Increases Risk Of Excessive Anticoagulation In Patients Taking Warfarin
2. Certain genes boost fish oils protection against breast cancer
3. DuPont introduces in-home personal protection from dangers of hurricanes
4. New way to protect brain from stroke damage
5. Picking prostanoids to provide protection
6. DuPont developing new protective suits for military, first responders
7. New research suggests early diet may play key role in protecting against childhood leukaemia
8. DHA-rich diet protects brain from Alzheimers damage, UCLA study shows
9. Purdue study finds antioxidant protects metal-eating plants
10. Carnegie Mellon researcher tests tools for protecting Anacostia River ecosystem from PCBs
11. Putting energy into heart protection

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... August 25, 2020 , ... ... in partnership with Essex Bio-Technology, a bio-pharmaceutical company specializing in Ophthalmology and ... study of SkQ1 ophthalmic solution in patients with moderate to severe Dry ...
(Date:8/21/2020)... ... August 18, 2020 , ... Sentien Biotechnologies, Inc., ... the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational New ... treatment of severe COVID-19. Approval of this IND allows Sentien to initiate a ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... in Princeton, NJ, have entered into license agreements with Housey Pharma’s HMI subsidiary ... Both Roche and J&J have annual Research and Development spending in excess of ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... 2020 , ... The SDX® Respiratory Gating System , ... reached its 20th anniversary of worldwide use. Introduced in the US over the ... University of Pennsylvania, University of Michigan, University of Maryland, University of California San ...
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... “We are ... Third Wave Bioactives. “It’s the only technology of its kind on the market and ... of onions with the protective capacity of traditional cultured ingredients, creating a natural way ...
(Date:7/10/2020)... , ... July 09, 2020 ... ... company, announced today that Massachusetts Institute of Technology (MIT) has expanded the ... license allows PathSensors to move into the point-of-care diagnostic market, focusing initially ...
(Date:7/7/2020)... ... July 06, 2020 , ... Bio-IT World has ... Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts General Hospital, Mission: Cure, and ... elite awards program, highlighting outstanding examples of how technology innovations and strategic initiatives ...
Breaking Biology Technology:
Cached News: